Protara Share Price

Protara Share Price

NASDAQ: TARA | Micro Cap | Healthcare
$2.34
+$0.03 (1.52%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Protara Stock Performance

Open
$2.42
Prev. Close
$2.31
Circuit Range
N/A
Day Range
$2.29 - $2.42
Year Range
$2.11 - $7.81
Volume
49,840
Average Traded
$2.34

Protara Share Price Today

As of 19 November 2026, Protara Therapeutics, Inc.'s share price is $2.34. The stock opened at $2.42, compared to its previous close of $2.31. During today's trading session, Protara Therapeutics, Inc.'s share price traded between $2.29 and $2.42, with an average price of $2.36. Over the past 52 weeks, the stock has recorded a high of $7.81 and a low of $2.11. In terms of performance, Protara Therapeutics, Inc.'s share price has declined by 49.79% over the last six months and is down 68.27% on a year-on-year basis.

Protara Share Price Chart

Line chart of the Protara price trend over the selected period. The price rose overall, ranging from 2.29 to 2.41, ending at 2.34.
$2.29$2.42
L
Show Current Price
H

Protara Stock Fundamentals & Key Indicators

Market Cap
$100.24M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.27
Revenue (TTM)
$0.00
Return On Equity (TTM)
-55.63%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-25.30%

Protara Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$17.31-$17.78-$21.67-$21.69
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-2.72%-21.88%-0.09%

Protara Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$65.95-$40.42-$44.60-$57.44
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A38.71%-10.34%-28.79%

Protara Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets49.969.310.2527.14
Current Assets159.5172.1668.7186.15
Total Assets209.47181.4578.95113.29
Non Current Liabilities2.123.364.485.47
Current Liabilities10.9410.966.155.74
Total Liabilities13.0614.3210.6311.21
Shareholders' Equity196.41167.1368.32102.08

Protara Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-56.37-35.81-37.56-26.46
Investing-139.4919.1653.1114.95
Financing82.72139.87-0.09-0.09

About Protara

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

Protara Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.50
$2.33
-5.68%
Oct 2026
$3.06
$2.46
-19.58%
Sep 2026
$3.83
$3.06
-23.28%
Aug 2026
$3.89
$4.00
+1.91%
Jul 2026
$3.88
$3.92
+2.75%
Jun 2026
$4.63
$3.81
-18.13%
May 2026
$5.38
$4.66
-12.57%
Apr 2026
$5.25
$5.33
+2.50%
Mar 2026
$6.28
$5.20
-18.37%
Feb 2026
$7.05
$6.37
-10.16%
Jan 2026
$5.30
$7.09
+33.27%
Dec 2025
$7.25
$5.32
-27.86%

Protara Share Price FAQs